162 related articles for article (PubMed ID: 14753416)
1. Calcineurin and cyclophilin D are differential targets of neuroprotection by immunosuppressants CsA and FK506 in ischemic brain damage.
Uchino H; Ishii N; Shibasaki F
Acta Neurochir Suppl; 2003; 86():105-11. PubMed ID: 14753416
[TBL] [Abstract][Full Text] [Related]
2. Differential neuroprotection by cyclosporin A and FK506 following ischemia corresponds with differing abilities to inhibit calcineurin and the mitochondrial permeability transition.
Uchino H; Minamikawa-Tachino R; Kristián T; Perkins G; Narazaki M; Siesjö BK; Shibasaki F
Neurobiol Dis; 2002 Aug; 10(3):219-33. PubMed ID: 12270685
[TBL] [Abstract][Full Text] [Related]
3. Cyclosporin A, but not FK506, prevents the downregulation of phosphorylated Akt after transient focal ischemia in the rat.
Yoshimoto T; Uchino H; He QP; Li PA; Siesjö BK
Brain Res; 2001 Apr; 899(1-2):148-58. PubMed ID: 11311876
[TBL] [Abstract][Full Text] [Related]
4. Cellular signaling mechanisms for stimulation of growth hormone secretion and growth hormone primary transcripts by immunosuppressant agents, FK506 and cyclosporin A, in cultured rat pituitary cells.
Ohye H; Sato M; Murao K; Matsubara S; Tokuda M; Takahara J
Neuroimmunomodulation; 1998; 5(6):309-17. PubMed ID: 9762012
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of arachidonic acid release by cytosolic phospholipase A2 is involved in the antiapoptotic effect of FK506 and cyclosporin a on astrocytes exposed to simulated ischemia in vitro.
Gabryel B; Chalimoniuk M; Stolecka A; Waniek K; Langfort J; Malecki A
J Pharmacol Sci; 2006 Sep; 102(1):77-87. PubMed ID: 16990701
[TBL] [Abstract][Full Text] [Related]
6. Three-dimensional structure and actions of immunosuppressants and their immunophilins.
Braun W; Kallen J; Mikol V; Walkinshaw MD; Wüthrich K
FASEB J; 1995 Jan; 9(1):63-72. PubMed ID: 7529736
[TBL] [Abstract][Full Text] [Related]
7. Amelioration by cyclosporin A of brain damage in transient forebrain ischemia in the rat.
Uchino H; Elmér E; Uchino K; Li PA; He QP; Smith ML; Siesjö BK
Brain Res; 1998 Nov; 812(1-2):216-26. PubMed ID: 9813336
[TBL] [Abstract][Full Text] [Related]
8. Molecular mechanisms of neuroprotective action of immunosuppressants--facts and hypotheses.
Kaminska B; Gaweda-Walerych K; Zawadzka M
J Cell Mol Med; 2004; 8(1):45-58. PubMed ID: 15090260
[TBL] [Abstract][Full Text] [Related]
9. A novel neuroprotective compound FR901459 with dual inhibition of calcineurin and cyclophilins.
Uchino H; Morota S; Takahashi T; Ikeda Y; Kudo Y; Ishii N; Siesjö BK; Shibasaki F
Acta Neurochir Suppl; 2006; 96():157-62. PubMed ID: 16671446
[TBL] [Abstract][Full Text] [Related]
10. Identification of the immunophilins capable of mediating inhibition of signal transduction by cyclosporin A and FK506: roles of calcineurin binding and cellular location.
Bram RJ; Hung DT; Martin PK; Schreiber SL; Crabtree GR
Mol Cell Biol; 1993 Aug; 13(8):4760-9. PubMed ID: 7687744
[TBL] [Abstract][Full Text] [Related]
11. FK506 and the role of immunophilins in nerve regeneration.
Gold BG
Mol Neurobiol; 1997 Dec; 15(3):285-306. PubMed ID: 9457703
[TBL] [Abstract][Full Text] [Related]
12. Roles of peptidyl-prolyl cis-trans isomerase and calcineurin in the mechanisms of antimalarial action of cyclosporin A, FK506, and rapamycin.
Bell A; Wernli B; Franklin RM
Biochem Pharmacol; 1994 Aug; 48(3):495-503. PubMed ID: 7520696
[TBL] [Abstract][Full Text] [Related]
13. A proposed molecular model for the interaction of calcineurin with the cyclosporin A-cyclophilin A complex.
Ivery MT
Bioorg Med Chem; 1999 Jul; 7(7):1389-402. PubMed ID: 10465413
[TBL] [Abstract][Full Text] [Related]
14. Neural roles of immunophilins and their ligands.
Sabatini DM; Lai MM; Snyder SH
Mol Neurobiol; 1997 Oct; 15(2):223-39. PubMed ID: 9396011
[TBL] [Abstract][Full Text] [Related]
15. Effects of immunosuppressants, calcineurin inhibition, and blockade of endoplasmic reticulum calcium channels on free fatty acid efflux from the ischemic/reperfused rat cerebral cortex.
Phillis JW; Diaz FG; O'Regan MH; Pilitsis JG
Brain Res; 2002 Dec; 957(1):12-24. PubMed ID: 12443975
[TBL] [Abstract][Full Text] [Related]
16. Nitric-oxide-synthase-mediated cyclic guanosine monophosphate production in neonatal rat cerebellar prisms is resistant to calcineurin inhibition.
Macleod MR; Butcher SP
Neurosci Lett; 2002 Mar; 322(1):41-4. PubMed ID: 11958839
[TBL] [Abstract][Full Text] [Related]
17. Crystal structure of human calcineurin complexed with cyclosporin A and human cyclophilin.
Jin L; Harrison SC
Proc Natl Acad Sci U S A; 2002 Oct; 99(21):13522-6. PubMed ID: 12357034
[TBL] [Abstract][Full Text] [Related]
18. Immunophilin regulation of neurotransmitter release.
Steiner JP; Dawson TM; Fotuhi M; Snyder SH
Mol Med; 1996 May; 2(3):325-33. PubMed ID: 8784785
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the protective effects of cyclosporin a and FK506 on abnormal cytosolic and mitochondrial Ca²⁺ dynamics during ischemia and exposure to high glutamate concentration in mouse brain slice preparations.
Yokoyama T; Tanoue T; Hasegawa E; Ikeda Y; Ohta S; Omi A; Kudo Y; Uchino H
J Pharmacol Sci; 2012; 120(3):228-40. PubMed ID: 23099321
[TBL] [Abstract][Full Text] [Related]
20. Immunophilins mediate the neuroprotective effects of FK506 in focal cerebral ischaemia.
Sharkey J; Butcher SP
Nature; 1994 Sep; 371(6495):336-9. PubMed ID: 7522303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
